A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)

Clinical trial NCT05394142 · UNKNOWN

Trial details

NCT number: NCT05394142
Sponsor: Fundació Sant Joan de Déu
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Polycystic Ovary Syndrome (PCOS)

Start date: 2022-05-24
Primary completion: 2025-04-01
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.